Selected Grants
Therapies for Glioblastoma Multiforme
ResearchPrincipal Investigator · Awarded by Jewish Communal Fund · 2022 - 2026Circle of Service Foundation Challenge Grant
Institutional SupportPrincipal Investigator · Awarded by Circle of Service Foundation · 2023 - 2025PVSRIPO in melanoma
ResearchCo-Mentor · Awarded by National Cancer Institute · 2020 - 2025Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas
ResearchCo Investigator · Awarded by National Institutes of Health · 2015 - 2022Therapies for Glioblastoma Multiforme
ResearchPrincipal Investigator · Awarded by Jewish Communal Fund · 2007 - 2022Research Training In Neuro-Oncology
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Institutes of Health · 1998 - 2016Adoptive Immunotherapy for GBM During Hematopoietic Recovery from Temozolomide
Clinical TrialCollaborator · Awarded by National Institutes of Health · 2009 - 2014Gene Targeted Therapy of Brain Tumors
ResearchCollaborator · Awarded by National Institutes of Health · 2009 - 2012Targeting Brain Tumor Stem Cells
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2011Research Training In Neuro-Oncology
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Institutes of Health · 2005 - 2010Temodar Resistance in CNS Tumors
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1992 - 2010Changes in Functional Status Across Therapy for Primary Gilioma
ResearchConsultant · Awarded by National Cancer Institute · 2006 - 2009TGFbeta-PTEN Interactions in Glioma Biology & Therapy
ResearchConsultant · Awarded by National Institutes of Health · 2006 - 2008Molecular Mechanisms of SPARC Mediated Glioma Invasion
ResearchConsultant · Awarded by National Institutes of Health · 2006 - 2008DNA Methylation and GSTP1 Gene Regulation in Gliomas
ResearchCo Investigator · Awarded by National Institutes of Health · 2002 - 2008Biomarker Studies for Novel Anti-Cancer Agents
ResearchConsultant · Awarded by National Institutes of Health · 2003 - 2008Imaging of O6-Alkylguianine-DNA Alkyltransferase
ResearchConsultant · Awarded by National Institutes of Health · 2002 - 2007Phase II Study of 44Gy from 131I-81C6 for CNS Tumors
ResearchCo Investigator · Awarded by National Institutes of Health · 2003 - 2006Astatine-211 & Radioiodine Labeled Octreotide Conjugates
ResearchInvestigator · Awarded by National Institutes of Health · 2001 - 2006Regional AGT Depletion of CNS and Leptomeningeal Tumors
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2002 - 2006AGT Depletion for therapy of CNS tumors
ResearchMentor · Awarded by National Institutes of Health · 2000 - 2005GCRC CAP
ResearchMentor · Awarded by National Institutes of Health · 2000 - 2005Therapy of Temodar plus O6-Benzulguanine in Malignant Glioma
ResearchCo Investigator · Awarded by National Institutes of Health · 2003 - 2005A Molecular Classification of Brain Tumors
ResearchCo Investigator · Awarded by National Institutes of Health · 2000 - 2003ZD1839 Therapy of Glioblastoma Multiforme
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2001 - 2003Intrathecal Busulfan Therapy of Neoplastic Meningitis
ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 1998 - 2002GRT-Photo-Documentary/Patients/Brain Tumors
ResearchPrincipal Investigator · Awarded by The Mary Duke Biddle Foundation · 1999 - 2002Same
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1999 - 2001Src On Primary And Matastatic Tumors Of The Cns
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1994 - 1999Src On Primary And Metastatic Tumors Of The Cns
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1997 - 1999Phase I Trial Of 06-Benzylguanine Plus Bcnu In Glioma
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 1996 - 1998Cyclophosphamide Resistance In Medulloblastoma
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1996 - 1998Cyclophosphamide Resistance In Medulloblastoma
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1995 - 1998Cyclophoshamide Resistance In Medulloblastoma
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1992 - 1998Phase I Trial Of 06-Benzylguanine Plus Bcnu In Glioma
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1995 - 1997Pediatric Oncology Group Studies
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 1995 - 1995Gluathione Modulation Of Alkylators In Medulloblastoma
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1992 - 1995Glutathione Modulation Of Alkylators In Medulloblastoma
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1993 - 1995Pediatric Oncology Group Studies
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1991 - 1994Src On Malignant Human Gliomas And Medulloblastomas
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1993 - 1994Melphalan Cytotoxicity And Resistance In Medulloblastoma
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1990 - 1991Neurobiology And Rational Therapy Of Human Medulloblastoma
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1987 - 1990Neurobiology And Rational Therapy Of Human Medulloblasto
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1986 - 1990External Relationships
- Istari Oncology
- Leaf Vertical
- Matrix Capital
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.